AP-120

N/A

Report date: 2025/01/02 16:15:00

Base Information

Drug NameAP-120

Drug Alias NameAP-120

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsDendritic cells stimulants

TargetsUpdating

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAP Biosciences Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

ATC CodeN/A